{"disease":{"id":"overweight-subjects","name":"overweight subjects"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04782024","title":"A Study to Investigate the Effect of 7-Keto on Resting Metabolic Rate in Overweight Adults","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":138,"lead_sponsor_name":"KGK Science Inc.","has_results":false},{"nct_id":"NCT07331389","title":"A Drug-Drug Interaction Study of HDM1002 and Metformin, Empagliflozin, Midazolam, Valsartan, and Warfarin","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":111,"lead_sponsor_name":"Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT07044167","title":"Innovative Functional Product for Overweight and Obesity","phase":"NA","overall_status":"COMPLETED","enrollment_count":70,"lead_sponsor_name":"Carmen Lucas Abellán","has_results":false},{"nct_id":"NCT04521738","title":"First-in-human Study to Assess Safety and Tolerability of a Single Subcutaneous Dose of SAR441255 in Lean to Overweight Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":48,"lead_sponsor_name":"Sanofi","has_results":false},{"nct_id":"NCT05815680","title":"A Study to Evaluate the Drug-drug Interactions (DDIs) of IBI362 With Metformin, Warfarin, Atorvastatin, Digoxin in Overweight or Obese Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":48,"lead_sponsor_name":"Innovent Biologics (Suzhou) Co. Ltd.","has_results":false}],"total":5},"guidelines":[],"source":"Drug Landscape verified database"}